Charles Schwab
ALVO icon

Charles Schwab’s Alvotech ALVO Stock Holding History

Charles Schwab’s Portfolio ALVO Stock Details ALVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
+11,685
New +$41.8K ﹤0.01% 3427

Other funds holding ALVO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $5.53B AUM 25.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $78.6M AUM 1.93% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Charles Schwab's ALVO Position: Q2 2026 in Review

Charles Schwab opened a new position in Alvotech (ALVO) in Q2 2026: 11,685 shares worth $43.1K. The stake represents ﹤0.01% of the portfolio and ranks #3427 among its holdings.

72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • Charles Schwab held 11,685 shares of Alvotech worth $43.1K as of Q2 2026.
  • Alvotech was a new Charles Schwab position in Q2 2026.
  • Alvotech made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3427 holding.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.